Anti-Phospho-MBS (MYPT1) (Thr853) pAb
Katalog-Nummer CY-P1025
Size : 50ug
Marke : MBL International
Contact local distributor :
Telefonnummer : +1 850 650 7790
Please Note: MBL International will be shutting down its operations effective December 31, 2024. Distribution of MBL products in the United States will be transferred to Cosmo Bio US on January 1st while European Distributors will remain unchanged. For any US inquiries regarding orders or support during this transition, reach out to Cosmo Bio: https://www.cosmobiousa.com/. For Non-US inquiries reach out to MBL in Japan: https://www.mblbio.com/.
| Target | MBS |
|---|---|
| Product Type | Antibody |
| Application | ELISA, WB |
| Clonality | Polyclonal |
| Conjugate | Unlabeled |
| Isotype | IgG |
| Immunogen | a synthetic phosphopeptide corresponding to residues surrounding Thr853 of human MBS/MYPT1 (KLH-conjugated ) |
| Host Species | Rabbit |
| Species Reactivity | Human, Chicken, Mouse, Rat |
| Formulation | Supplied in 20 mM phosphate buffer (pH 7.5), 300 mM NaCl, 50 % glycerol. |
| Research Area | Cell Biology, Drug Discovery, Signal Transduction |
| Description/Background | The expression of a constitutively active form of Rho-kinase induced stress fiber and focal adhesion formation in fibroblasts and an increase in the level of myosin light chain (MLC20) phosphorylation. These results in smooth muscle and in non-muscle cells are attributed to an increase in MLC20 phosphorylation and this is thought to reflect the inhibition of myosin phosphatase (MP). MP is composed of three subunits: a catalytic subunit of type 1 phosphatase delta isoform, PP1c delta, and two non-catalytic subunits, 110 and 20 kDa. The 110 kDa subunit is a targeting molecule and thus has been termed myosin phosphatase target subunit 1 (MYPT1) or myosin-binding subunit (MBS). MBS/MYPT1 is the key molecule involved in regulation of MP activity. Phosphorylation by Rho-kinase inhibited MP activity and this reflected a decrease in Vmax. Activity of MP with different substrates also was inhibited by phosphorylation. Two major sites of phosphorylation on chicken MBS/MYPT1 were Thr696 and Thr853. Various point mutations were designed for these phosphorylation sites. Following thiophosphorylation by Rho-kinase and assays of phosphatase activity it was determined that Thr695 was responsible for inhibition. Rho-kinase, which is activated by GTP-RhoA, phosphorylated MBS/MYPT1 and consequently inactivated myosin phosphatase (MP). Over-expression of RhoA or activated RhoA in NIH 3T3 cells increased phosphorylation of MBS/MYPT1 and MLC20. Thus, Rho appears to inhibit myosin phosphatase through the action of Rho-kinase. |
| Storage Temperature | Store at -20°C |
| Protocols | ELISA, WB |
| Sensitivity | Phospho-MBS/MYPT1 Thr853 Antibody detects endogenous MBS/MYPT1 only when phosphorylated at threonine853. The antibody does not recognize other myosin phosphatase regulatory subunit. |
| Molecular Weight | 135 kDa |
| Concentration | 1.0 mg/mL |
| Source | This polyclonal antibody is produced by immunizing rabbit with a synthetic phosphopeptide corresponding to residues surrounding Thr853 of human MBS/MYPT1. |
| Purification | IgG is purified by peptide-Sepharose affinity chromatography. |
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
CY-P1025
Antibody
50 µg